Recurring yeast infections are usually driven by a combination of factors rather than a single cause. The most common triggers include shifts in vaginal bacteria, hormonal changes, antibiotic use, and in some cases, an immune system that’s less efficient at clearing the fungus. Clinically, recurring infections are defined as three or more episodes in a year (by U.S. guidelines) or four or more per year (by European standards), and roughly 5 to 8 percent of women experience them.
How Protective Bacteria Keep Yeast in Check
The vagina naturally contains both yeast (most commonly Candida albicans) and beneficial bacteria, particularly several species of Lactobacillus. These bacteria are the first line of defense against yeast overgrowth. They produce lactic acid and other compounds that directly inhibit Candida growth, block yeast from attaching to vaginal tissue, and prevent it from forming the thread-like filaments (hyphae) it uses to invade cells and cause symptoms.
Not all Lactobacillus species offer equal protection. A vaginal microbiome dominated by L. crispatus is associated with stronger resistance to yeast infections, while one dominated by L. iners is linked to more frequent candidiasis. Anything that depletes or shifts this bacterial community opens the door for yeast to multiply unchecked.
Antibiotics and the Microbiome
Antibiotic use is one of the most well-established triggers. Broad-spectrum antibiotics don’t just target the infection you’re treating. They can wipe out vaginal Lactobacillus populations at the same time, removing the bacterial barrier that normally suppresses yeast. This is why many women develop a yeast infection shortly after finishing a course of antibiotics for a sinus infection, urinary tract infection, or other unrelated illness.
Interestingly, even antifungal treatment itself can compound the problem. Fluconazole, the standard oral antifungal used for yeast infections, has been shown to reduce the abundance of vaginal Lactobacilli. This creates a frustrating cycle: treating the yeast infection can weaken the very bacteria you need to prevent the next one.
Hormonal Changes and Estrogen
Estrogen plays a significant role in yeast infection risk. Higher estrogen levels increase the glycogen content of vaginal cells, which provides more fuel for yeast to feed on. Estrogen also appears to directly support Candida’s ability to grow its invasive filament structures by influencing the metabolism of specific sugar compounds the fungus uses for cell wall formation.
This explains why certain life stages and medications carry higher risk. Pregnancy, hormonal contraceptives (especially higher-estrogen formulations), and hormone replacement therapy in postmenopausal women are all associated with increased rates of vaginal yeast infections. If your recurring infections started around the same time you began a new birth control method or hormone therapy, the connection is worth exploring with your provider.
Blood Sugar and Diabetes
Elevated blood glucose creates a more hospitable environment for yeast. Women with poorly controlled diabetes or prediabetes face a notably higher risk of recurrent infections because excess sugar in vaginal secretions gives Candida an abundant food source. If you’re getting frequent yeast infections and haven’t had your blood sugar checked recently, undiagnosed insulin resistance or diabetes could be a hidden driver.
Immune System Differences
Some women are genetically predisposed to recurring infections because of how their immune system recognizes and clears Candida. One well-studied example involves mannose-binding lectin (MBL), a protein that helps the immune system identify and destroy pathogens. Women with genetic variants that produce lower levels of MBL are significantly more susceptible to recurrent vaginal infections. In one large study, carrying even one copy of the low-production gene variant nearly tripled the risk of recurrent infections compared to women without it.
Women with these variants had measurably lower MBL levels in their blood, which translated to less efficient pathogen clearance. This helps explain why some women seem to do everything “right” and still get infection after infection. It’s not a hygiene issue or a behavioral failing. It’s a difference in innate immune architecture. Other immune-related factors, including certain allergic tendencies and gene variations affecting inflammatory responses, have also been linked to higher recurrence rates.
Clothing and Moisture
Yeast thrives in warm, moist environments. Synthetic underwear traps heat and moisture against the skin, creating ideal conditions for overgrowth. Cotton is breathable and wicks away excess sweat, which is why it’s consistently recommended for women prone to recurring infections. A synthetic underwear with a cotton crotch panel isn’t a sufficient substitute, since that small panel doesn’t fully protect you from the surrounding synthetic fabric and won’t breathe the way 100% cotton does.
Panty liners also decrease breathability and can cause irritation. If you’re dealing with recurrent infections, going without underwear at night and wearing loose-fitting pajamas or boxer shorts increases airflow and supports healing. Tight clothing during the day, particularly workout leggings worn for extended periods after exercise, can have a similar trapping effect.
Resistant Yeast Species
Most yeast infections are caused by Candida albicans, which typically responds well to standard antifungal treatment. But some recurrent infections involve non-albicans species, particularly Candida glabrata, which can be resistant to the standard treatments. If you’ve been treating infections with over-the-counter antifungals or short courses of fluconazole and they keep coming back, it’s possible you’re dealing with a species that doesn’t respond to those medications. Getting a culture (not just a visual diagnosis) can identify the exact species and guide more effective treatment.
How Recurring Infections Are Managed
For women who meet the threshold for recurrent vulvovaginal candidiasis, the standard approach involves two phases. First, the current active infection is treated. Then a maintenance regimen follows, typically involving a weekly oral antifungal for six months. This prolonged suppressive therapy aims to keep yeast populations low while the vaginal ecosystem stabilizes.
The challenge is that roughly half of women experience another infection after stopping maintenance therapy. This is partly because the underlying causes (hormonal patterns, immune factors, microbiome composition) haven’t changed. Addressing the root drivers listed above, where possible, improves the odds of breaking the cycle. That might mean switching contraceptive methods, improving blood sugar control, changing underwear habits, or being more strategic about antibiotic use when alternatives exist.
Researchers have also explored whether restoring Lactobacillus populations through vaginal probiotics could help prevent recurrence. The logic is sound, given how central these bacteria are to yeast defense, but results so far have been mixed enough that it’s not yet a standard recommendation. Focusing on the modifiable risk factors you can control remains the most reliable strategy.